New nanoparticle can help detect cancer at early stages

01/23/2008 | Examiner (Washington, D.C.), The

Researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine have developed nanoparticles that help preserve biomarkers, which can indicate cancer and other diseases, a step that could lead to cancer detection at much earlier stages. Different biomarkers can be tested by altering the nanoparticles.

View Full Article in:

Examiner (Washington, D.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN